Similarly, glycyrrhetinic acid (GA) exacerbates ferroptosis in breast cancer by inhibiting xCT expression and GPX4 activity, depleting GSH (Wen Y et al., 2021). This evidence concerns the gene GPX4 and breast carcinoma.